A comparison of responses to intravitreal bevacizumab, ranibizumab, or aflibercept injections for neovascular age-related macular degeneration
Author:
Publisher
Springer Science and Business Media LLC
Subject
Ophthalmology
Link
http://link.springer.com/article/10.1007/s10792-016-0391-4/fulltext.html
Reference26 articles.
1. Andreoli CM, Miller JW (2007) Anti-vascular endothelial growth factor therapy for ocular neovascular disease. Curr Opin Ophthalmol 18(6):502–508. doi: 10.1097/ICU.0b013e3282f0ca54
2. Rosenfeld PJ, Rich RM, Lalwani GA (2006) Ranibizumab: phase III clinical trial results. Ophthalmol Clin N Am 19(3):361–372. doi: 10.1016/j.ohc.2006.05.009
3. Ferrara N, Damico L, Shams N, Lowman H, Kim R (2006) Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration. Retina 26(8):859–870. doi: 10.1097/01.iae.0000242842.14624.e7
4. Heier JS, Boyer D, Nguyen QD, Marcus D, Roth DB, Yancopoulos G, Stahl N, Ingerman A, Vitti R, Berliner AJ, Yang K, Brown DM et al (2011) The 1-year results of CLEAR-IT 2, a phase 2 study of vascular endothelial growth factor trap-eye dosed as-needed after 12-week fixed dosing. Ophthalmology 118(6):1098–1106. doi: 10.1016/j.ophtha.2011.03.020
5. Ladewig MS, Ziemssen F, Jaissle G, Helb HM, Scholl HP, Eter N, Bartz-Schmidt KU, Holz FG (2006) Intravitreal bevacizumab for neovascular age-related macular degeneration. Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 103(6):463–470. doi: 10.1007/s00347-006-1352-5
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Comparative efficacy of aflibercept and ranibizumab in the treatment of age-related macular degeneration with retinal pigment epithelial detachment: a systematic review and network meta-analysis;BMC Ophthalmology;2023-11-21
2. Changes on optical coherence tomography angiography and fluorescein angiography in eyes with neovascular age-related macular degeneration;International Journal of Ophthalmology;2022-11-18
3. The intervention of epithelial-mesenchymal transition in homeostasis of human retinal pigment epithelial cells: a review;Journal of Histotechnology;2022-10-02
4. Harnessing the Neuroprotective Behaviors of Müller Glia for Retinal Repair;Frontiers in Bioscience-Landmark;2022-05-30
5. Anti‐drug antibodies to brolucizumab and ranibizumab in serum and vitreous of patients with ocular disease;Acta Ophthalmologica;2022-02-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3